FormWeb • darbepoetin alfa

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Add Formweb to your mobile device

Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

darbepoetin alfa

darbepoetin alfa

Restricted Erythropoietin Formulary
Restricted Aranesp --> Restricted to Outpatient Medical.
Therapeutic Interchange

Drug Name	Form	Strength
Aranesp	SOLUTION, INJECTABLE	25 mcg/mL, 40 mcg/mL, 60 mcg/mL
Aranesp	SOLUTION, INJECTABLE	100 mcg/mL, 200 mcg/mL, 300 mcg/mL
Aranesp	SOLUTION, INJECTABLE	500 mcg/mL

VIEW MORE Hematopoietic Agents
CLASS

Comments:

Aranesp Medication Guide

Aranesp is converted to Procrit. See Erythropoietin Formulary for dose conversions.

Reviewed: December 12, 2006

REMS: View FDA REMS Info

Last updated: Dec. 22, 2023

Black Box Warning: Mortality, serious CV events, tumor progression or recurrence
Formulary, Not Routinely Stocked: 25 mcg/mL

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.